We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 97.50 | 95.00 | 100.00 | 97.50 | 97.50 | 97.50 | 4,188 | 07:36:53 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.46 | 13M |
From Apr 2019 to Apr 2024
TIDMFDBK
RNS Number : 4565K
Feedback PLC
21 September 2016
21 September, 2016
Feedback plc
("Feedback" or the "Company")
Trading Update
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to announce an update on current trading.
The Company has made good progress in conjunction with Alliance Medical on a technical solution that would allow the integration of TexRAD into Alliance's network of PET/CT scanners in UK hospitals and a prototype version has already been demonstrated to potential users. The next steps will include applying for a CE mark for a medical device which provides analysis of lung PET/CT images with added prognostication through TexRAD.
The number of new purchase orders received for TexRAD research versions has increased significantly in recent months leading to expectations of a much improved cash inflow over the next few months. However this follows a period of about 12 months where sales of research versions were at a lower level and mainly to existing customers. We are now assessing whether the present high level of sales can be continued with additional sales support.
Our final results for the financial year ended 31st May 2016 are scheduled to be announced in October 2016. These are expected to show turnover significantly ahead of the previous year and a substantially reduced operating loss.
For further information contact:
Feedback plc Tel: 01954 Alastair Riddell 718072 Allenby Capital Limited (Nominated Tel: 020 3328 Adviser and Joint Broker) 5656 David Worlidge / James Thomas Peterhouse Corporate Finance Tel: 020 7469 Ltd (Joint Broker) 0936 Lucy Williams / Duncan Vasey
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTBBGDCDDDBGLB
(END) Dow Jones Newswires
September 21, 2016 07:30 ET (11:30 GMT)
1 Year Feedback Chart |
1 Month Feedback Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
